Clinical Trials Logo

Filter by:
NCT ID: NCT00664391 Completed - Hygiene Clinical Trials

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Breeze.

NCT ID: NCT00663390 Completed - Hygiene Clinical Trials

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Delicata Pocket.

NCT ID: NCT00663325 Completed - Hygiene Clinical Trials

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.

NCT ID: NCT00663273 Completed - Hygiene Clinical Trials

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.

NCT ID: NCT00662961 Completed - Forehead Clinical Trials

Forehead Lift Fixation

Forehead
Start date: January 2007
Phase: N/A
Study type: Interventional

To compare periosteum versus bone fixation in forehead lift.

NCT ID: NCT00661401 Completed - Clinical trials for Common Variable Immunodeficiency

Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

Start date: January 2002
Phase: N/A
Study type: Interventional

Objective: Measure serum IgG antibody to Streptococcus pneumoniae serotypes 1, 3, 5, 6B, 9V e 14, Haemophilus influenzae type b and tetanus toxoid in patients with primary antibody deficiencies who were treated with subcutaneous immunoglobulin infusions.

NCT ID: NCT00661102 Completed - Breast Cancer Clinical Trials

A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).

Start date: December 2008
Phase: Phase 3
Study type: Interventional

This 3 arm study will compare the prophylactic effect of topical corticosteroids, Bepantol or placebo on hand-foot syndrome in patients receiving Xeloda for treatment of metastatic breast cancer, metastatic colorectal cancer or adjuvant treatment of colorectal cancer. Patients who have been receiving oral Xeloda for at least 5 days will be randomized to receive prophylactic treatment with either placebo, topical corticosteroids or Bepantol. The anticipated time on study treatment is until disease progression or development of hand-foot syndrome, and the target sample size is 500+ individuals.

NCT ID: NCT00660881 Completed - Clinical trials for Systemic Lupus Erythematosus

Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease

Start date: May 2008
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to assess the safety of epratuzumab in patients with SLE.

NCT ID: NCT00660803 Completed - Breast Cancer Clinical Trials

Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Start date: May 2008
Phase: N/A
Study type: Observational

Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.

NCT ID: NCT00660777 Completed - Clinical trials for Obstructive Sleep Apnea

Effects of OroPharyngeal Exercises on Patients With Moderate Obstructive Sleep Apnea

Start date: February 2004
Phase: Phase 3
Study type: Interventional

Background: Upper airway muscle weakness plays an important role in the genesis of obstructive sleep apnea (OSA). Oropharyngeal exercises are derived from speech therapy consisting of isometric and isotonic exercises directed to tongue, soft palate and lateral pharyngeal wall. We hypothesized that oropharyngeal exercises will attenuate OSA severity. We will include 30 moderate OSA patients (apnea-hypopnea index (AHI), between 15 and 30 events/hour) that will randomize to 3 months of general measurements and daily nasal lavage (n=15, control) or daily oropharyngeal exercises (~30 min) plus nasal lavage (n=16). Full polysomnography, anthropometric measurements, questionnaires derived from Berlin, Epworth and Pittsburgh evaluating quantitatively (range) snoring frequency (0-4) and intensity (1-3), daytime sleepiness (0-24) and sleep quality (0-21), respectively will be performed at baseline and study end.